/Companies

Mobiamedical

4 known investors

Find your way into Mobiamedical

Sign up to see every warm intro you have to Mobiamedical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Mobiamedical team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.

Founders & leadership

JCJordan Curnes
Jordan CurnesCo-Founder

Investors · 4

Frequently asked questions

What does Mobiamedical do?
Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.
Who founded Mobiamedical?
Mobiamedical was founded by Jordan Curnes.
Who are Mobiamedical's investors?
Mobiamedical's investors include Green Park & Golf Ventures, Longitude Capital, OUP (Osage University Partners), US Venture Partners.